Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 1

2(40.0%)

Phase 2

1(20.0%)

5Total

N/A(2)

Phase 1(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06048510Not ApplicableRecruiting

New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia.

Role: collaborator

NCT02724566Phase 1Completed

Effect of Apelin on Insulin Sensitivity in Type 2 Diabetic Volunteers

Role: collaborator

NCT04657783Recruiting

French National Cohort of People With Type 1 Diabetes

Role: collaborator

NCT01153048Phase 1Completed

Trial on an Educative Structured Intervention by Peer Educators to Improve HbA1c of Patients With Type 2 Diabetes in the Sikasso Region in Mali

Role: collaborator

NCT01956162Not ApplicableCompleted

Evaluation of a New Device "Orthèse Diabète" in the Healing of Foot Ulcers in Diabetic Patients

Role: collaborator

NCT01930110Phase 2Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) During Exercise in Adults With Type 1 Diabetes

Role: collaborator

All 6 trials loaded